Farther Finance Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Farther Finance Advisors’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5	Closed	-$1.58K	–	3771
2023 Q4	$1.58K	Sell	5 -8	-62%	-$1.55K	﹤0.01%	2527
2023 Q3	$2.2K	Buy	13 +10	+333%	+$1.88K	﹤0.01%	1819
2023 Q2	$651	Buy	3 +1	+50%	+$214	﹤0.01%	2074
2023 Q1	$363	Hold	2	–	–	﹤0.01%	2082
2022 Q4	$393	Buy	+2	New	+$429	﹤0.01%	1879

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Farther Finance Advisors's KRTX Position: Q1 2024 in Review

Farther Finance Advisors sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 5 shares — an estimated $1.58K sold.

Farther Finance Advisors first reported a position in KRTX in Q4 2022 and held it in 5 quarters. The position peaked at $2.2K in Q3 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Farther Finance Advisors reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Farther Finance Advisors sold 5 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.58K.
Farther Finance Advisors first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
Farther Finance Advisors's Karuna Therapeutics, Inc. Common Stock position peaked at $2.2K in Q3 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Farther Finance Advisors's 13F filing for Q1 2024, filed 14 May 2024.